US2013324462A1PendingUtilityA1
Method of Reducing The Effects of Chemotherapy Using Flagellin Related Polypeptides
Est. expiryDec 2, 2023(expired)· nominal 20-yr term from priority
A61P 3/00A61P 29/00A61P 25/00A61P 3/04A61P 1/00A61P 13/12A61K 38/164
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The use of flagellin and flagellin related polypeptides for reducing cancer treatment side effects in mammals is described.
Claims
exact text as granted — not AI-modified1 .- 7 . (canceled)
8 . A method of reducing a side effect of cancer treatment in a mammal in need thereof, comprising administering a therapeutically effective amount of a composition comprising flagellin, wherein the cancer therapy comprises radiation therapy and cisplatinum.
9 . The method of claim 8 , wherein the mammal is a human.
10 . The method of claim 8 , wherein the cisplatinum is administered at 50-270 mg/m 2 /day.
11 . The method of claim 8 , wherein the side effect is one or more of myelosuppression, renal toxicity, weight loss pain, nausea, vomiting, diarrhea, constipation, anemia, malnutrition, hair loss, numbness, changes in tastes, loss of appetite, thinned or brittle hair, mouth sores, memory loss, hemorrhage, cardiotoxicity, hepatotoxicity, ototoxicity, and post-chemotherapy cognitive impairment.
12 . The method of claim 11 , wherein the behavioral change is limited mobility.
13 . The method of claim 11 , wherein the side effect is selected from the group consisting of: myelosuppression, renal toxicity, and weight loss.
14 . The method claim 11 , wherein the mammal is a human.
15 . The method of claim 11 , wherein the cisplatinum is administered at 50-270 mg/m 2 /day.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.